Cargando…
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19
Autores principales: | Oudit, Gavin Y, Pfeffer, Marc A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224688/ https://www.ncbi.nlm.nih.gov/pubmed/32388547 http://dx.doi.org/10.1093/eurheartj/ehaa414 |
Ejemplares similares
-
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors
por: Sama, Iziah E, et al.
Publicado: (2020) -
Patiromer for the management of hyperkalemia in heart failure with reduced
ejection fraction: the DIAMOND trial( )
por: Butler, Javed, et al.
Publicado: (2022) -
Disinfection of Escherichia coli in ice by surface dielectric barrier discharge plasma
por: Guo, Yuntao, et al.
Publicado: (2021) -
Good Codons, Bad Transcript: Large Reductions in Gene Expression and Fitness Arising from Synonymous Mutations in a Key Enzyme
por: Agashe, Deepa, et al.
Publicado: (2013) -
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial
por: Pocock, Stuart J, et al.
Publicado: (2021)